SXTC icon

China SXT Pharmaceuticals

6 hedge funds and large institutions have $65.5K invested in China SXT Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$28K 105,039 +59,519 +131%
VF
2
Virtu Financial
New York
$11K 39,427 -49,730 -56%
Renaissance Technologies
3
Renaissance Technologies
New York
$10K 34,500 +34,500 New
Citadel Advisors
4
Citadel Advisors
Florida
$7.02K 24,410 +24,410 New
UBS Group
5
UBS Group
Switzerland
$5.1K 17,945 +7,329 +69%
TSS
6
Two Sigma Securities
New York
$4.4K 15,506 -29,144 -65%
Millennium Management
7
Millennium Management
New York
-67,648 Closed
CFGS
8
Concourse Financial Group Securities
Alabama